Contribute Try STAT+ Today

Hello, everyone, and how are you today? A bright shiny sun and cool breezes are enveloping the Pharmalot campus, a decidedly welcome shift from the muggy temperatures of the past few days. Naturally, this calls for a hot cup of stimulation. Our choice today is mocha nut fudge, just for a change of pace. Feel free to join us or grab a bottle of water, if you prefer. Meanwhile, we have assembled the latest menu of tidbits to help you get started on your proverbial journey today. Hope you conquer the world, and do keep safe. …

President Trump and Mike Lindell, the creator of MyPillow and an avowed supporter, participated in a July meeting at the White House regarding the use of oleandrin as a potential therapeutic for Covid-19, CNN reports. Oleandrin is an extract from the plant Nerium oleander. The raw oleander plant is highly toxic, and consumption of it can be fatal. Three infectious disease specialists say enthusiasm for the compound, made using a toxic shrub, is not only strange, but disturbing, because it’s only been tested in laboratory dishes.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Might one observe that given this statistic – “The filings cited more than 200,000 deaths in the U.S. ” – one could argue that the $2.2 Trillion figure ‘merely’ asks for $10 K USD / life lost. One might but the argument would be as absurd as the figure specified, given the (relatively) platy assets of Purdue and the family.

Comments are closed.

Your daily dose of news in health and medicine

Privacy Policy